Physiomics plc announced that Dr. Christophe Chassagnole's job title has changed from Chief Operating Officer to Chief Scientific Officer. This title aligns more closely with Dr. Chassagnole's current role and responsibilities and the expectation that, going forward, he will spend more time focused on the Company's personalised medicines initiatives. The change builds on the ongoing restructuring of the board which commenced last year with the hiring of two highly experienced Non-Executive Directors.